Objectives:

Currently, cardiovascular disease is one of the main causes of mortality and morbidity in Western developed countries, being the cause of around 50% of deaths in the population of these countries. There are various risk factors that increase the probability of suffering from cardiovascular disease, among which we can differentiate non-modifiable ones, which include variables such as age, sex or genetic factors, and other modifiable ones, of greater interest, such as high blood pressure, smoking, diabetes mellitus and dyslipidemia.

The main objective of this course is to address the latest advances being made in lipid metabolism research and its importance in the development of cardiovascular disease.

Aimed at:

Health professionals and researchers who are interested in expanding their knowledge of lipid metabolism and cardiovascular disease.

Organized by:

Investigation Group Dyslipidemias Primary. Aragón Health Research Institute (IIS Aragón).

Investigation Group Atherothrombosis. University of Navarra Clinic (CUN).

CIBERCV

Coordination:

Irene Gracia Rubio, PhD. Postdoctoral researcher Sara Borrell. Primary Dyslipidemia Group. Aragón Health Research Institute. Miguel Servet University Hospital. CIBERCV CB16/11/00451.

Joshua Orb, PhD. Senior Researcher, Head of the CIMA Atherothrombosis group. University of Navarra. Member of the atherothrombosis group of CIBERCV CB16/11/00483.

Registration:

A minimum attendance of 80% will be required to issue the certificate.

Registration open until October 10, 2023: